The discussion about the risks of navigating overlapping domains with an interesting perspective. The scenarios presenting two companies selling the same pharmaceuticals have expanded the risk management discussion.

For example, if you had two companies that sold pharmaceuticals and they happened to have a lot of customers with overlapping conditions (e.g. heart disease and stroke), you would certainly not want to send that customer to the other pharmaceutical company for their condition because the customer may never come back

By having a person from the rival company be involved in evaluating and covering the claim, that company could potentially share this knowledge with their customers through advertising or at seminars.

Under the scenario, you presented, under what circumstances would you send your customers with heart disease or stroke to the competitor and why?